Recently, medical science and technology have made remarkable advances and have prolonged the average human life span. As a result, a variety of diseases of aging have emerged. Alzheimer's disease (AD) is one of the senile dementias, and approximately 12 million people are estimated to suffer from AD in Japan, Europe and the U.S.A. A steady increase in the number of AD patients can be predicted with certainty in the near future.
Synthesis and Muscarinic Activity of Novel Aniline
with 3a in 7.7% yield (procedure B). Direct alkylation of anilines (1) with 3a, b gave N-monosubstituted aniline derivatives (5h-l) in low yields (procedure C). Anilines with an electron-withdrawing group at the ortho-or para-position (9a-q) were provided by aromatic nucleophilic substitution of the corresponding halobenzenes (7) in good yield (procedure D). 2-Carbamoyl derivatives (9r, s) were prepared by hydrolysis of the corresponding cyano compounds (9l, o) with H 2 SO 4 (procedure E).
We found a very interesting ring expansion reaction in procedure C (Chart 3). Alkylation of aniline derivatives (1i, k, l) with 3a formed the ring expanded products 10a-c in addition to the desired substituted products 5i, k, l. Miyano and his co-workers reported similar ring expansion reactions of 5-trichloromethyl-or 5-dichloromethyl-1-azabicyclo [3.3 .0]octanes to dichloro-and chloro-1-azabicyclo [3.3.1]nonanes, respectively, and synthesized various azabicyclo[3.3.1]nonane analogs. 9) 2-Chloroaniline (1i) was allowed to react with 3a to afford N- (1-azabicyclo[3.3 .0] octan-5-yl)methyl-2-chloroaniline (5i) and N-(1-azabicyclo [3.3.1]nonan-5-yl)-2-chloroaniline (10a) in yields of 44.1% and 30.4%, respectively. The structure of the ring expansion product 10a was characterized by 1 H-NMR, 13 C-NMR, and MS spectra. The 1 H-NMR spectrum of 10a showed methylene signals of the [3.3.1]nonane ring: d 3.01 (2H, s, 9-CH 2 ), 1.55-1.62, 2.00-2.14 (each 2H, m, 3,7-CH 2 ), 1.83-1.95, 2.27-2.33 (each 2H, m, 4,6-CH 2 ) and 2.97-3.07 (4H, m, 2,8-CH 2 ) in contrast to the signals of 5i: d 1.59-1.70 (2H, m, 3,7-CH 2 ), 1.70-1.92 (6H, m, 3,4,6,7-CH 2 ), 2.62-2.71 and 3.04-3.12 (each 2H, m, 2,8-CH 2 ), d 2.98 (2H, d, Jϭ5 Hz, N-CH 2 -C). Characteristic 13 C-NMR peaks of 10a were observed at d 48.7 due to the bridgehead carbon (5-C) and 59.9 corresponding to the C-CH 2 -N (9-C) carbon in comparison with those of 5i: d 72.8 (5-C) and 52.1 (HN-CH 2 -C). The ring expansion products were given by the rearrangement of 5-chloromethyl-1-azabicyclo [3.3 .0]octane (3a) via an aziridinium ion formed by the intramolecular nucleophilic attack of nitrogen on the chloromethyl group. An amine nucleophilically attacks at the methylene carbon of the aziridinium ring (path a) or at the bridgehead carbon (path b) to afford 5-aminomethyl-1-azabicyclo [3.3. 0]octane at 5-amino-1-azabicyclo[3.3.1]nonane, respectively. N-(1-Azabicyclo[3.3.1]nonan-5-yl)-3-cyanoaniline (10b) and the 2-(trifluoromethyl)aniline congener (10c) were similarly obtained from the reactions of 1k, l and 3a in 19.6% and 33.2% yields, respectively ( Table 2) . 
Pharmacological Results and Discussion
We have already shown that quinoline and naphthalene derivatives with a 1-azabicyclo[3.3.0]octane ring had strong affinities for the muscarinic receptor.
8) Therefore, aniline derivatives can be expected to have a strong effect on the muscarinic receptor.
The compounds thus prepared were tested in vitro for their affinity to M 1 and M 2 receptors, and in vivo for behavioral efficacy to scopolamine-induced dementia models.
The affinity for the muscarinic receptor of aniline derivatives having a 1-azabicyclo[3.3.0]octane ring was examined and the results are shown in Table 1 .
Initially, the effect of the substituent R 1 of the benzene ring was examined. The affinity of aniline derivatives 5 and 9 (nϭ1, R 2 ϭR 3 ϭH) for the M 1 receptor decreased in the order of 5n (R 1 ϭ2-NO 2 )Ͼ5l (2-CF 3 )Ͼ5e (2-F)Ͼ9l (2-CN)Ͼ9r (2-CONH 2 )Ͼ5i (2-Cl). Compounds with a substituent at the 3-or 4-position (5k, 5m, 9c, and 9m) showed weaker M 1 activities than the 2-substituted derivatives. The ethylene-chained compounds (nϭ2, R 2 ϭR 3 ϭH) were ranked for M 1 affinity as follows: 9f (R 1 ϭ2-NO 2 , free base of SK-946)Ͼ9o (2-CN)Ͼ5j (2-Cl)Ͼ9s (2-CONH 2 )Ͼ5h (2-F). These com- pounds showed high selectivity to the M 1 receptor, and their M 1 receptor affinities were stronger than those of 4-substitued derivatives (9g and 9p).
Among the N-methyl derivatives ((nϭ1, R 2 ϭH, R 3 ϭMe), 5c (R 1 ϭ2-Ph), 5f (2-F), 5g (2-CF 3 ), 9d (2-NO 2 ) and 9n (2-CN) had almost the same strong activities for the M 1 receptor, but the M 1 /M 2 selectivity was low except for 9n. The 3-or 4-substituted derivative (5d or 9e) and unsubstituted derivative (5a) were much weaker than the N-methyl derivatives. The ethylene-chained compounds (nϭ2, R 2 ϭH, R 3 ϭMe) were ranked for M 1 affinity as follows:
The affinity of compounds with NO 2 substitution was compared. Under the conditions R 1 ϭ2-NO 2 in aniline derivatives, compound 9f (nϭ2, R 2 ϭR 3 ϭH) showed the highest M 1 affinity and high M 1 selectivity in 2-nitroaniline derivatives. Some other aniline derivatives (9b, 9d, and 9h) also had high affinity for the M 1 receptor. The introduction of a substituent at the 4-position decreased the activity (9j and 9k). In the 2-cyano compounds (R 1 ϭ2-CN), 2-cyano-N-methylaniline derivatives (9n and 9q) had high binding activity to the M 1 receptor.
Similarly to the above result, the introduction of a strong electron-withdrawing group to the aniline derivative enhanced affinity for the M 1 receptor. Compounds which had a substituent at the 2-position exhibited stronger M 1 activities than 4-substituted derivatives. Some compounds which introduced a substituent at the 2-position on the aniline had strong affinity for the M 1 receptor, but less selectivity to the M 1 receptor. Two compounds were chosen as desirable samples for the in vivo test. Thus, compound 9f had the most potent affinity for the M 1 receptor, and 9l had the most M 1 selectivity of the compounds tested, having M 1 receptor selectivity more potent than 1.0 mM. 9f was more potent and had higher selectivity than (Ϫ)-YM796 and SR46559, and 9l had more M 1 selectivity than these. The compound 9f ameliorated scopolamine-induced impairment in passive avoidance tasks at 1.0 mg/kg (p.o.) ( Table 3 ). The agonistic property of 9f was confirmed by receptor-stimulated phosphoinositide hydrolysis in primary cultured rat fetal hippocampal neuronal cells preloaded with [ 3 H]-myo-inositol (Table 4) . Inositol phosphate (IP) production was expressed as
3 H]-myo-inositol)%. 9f fumarate increased IP production at a concentration of more than 10
The affinity for the muscarinic receptor of aniline derivatives with a 1-azabicyclo[3.3.1]nonane moiety was examined ( Table 2 ). These compounds, 10a-c had unexpectedly strong affinity for the muscarinic receptor. Compound 10a had an affinity for the M 1 receptor with a K i value of 59 nM, and high selectivity to the M 1 receptor. However, this compound was less active in ameliorating impairment in passive avoidance tasks than we expected (Table 3) .
Experimental
All melting points were determined on a Yanagimoto micro-melting point apparatus and are uncorrected. Infrared (IR) spectra were taken with a Perkin-Elmer 1600 spectrometer. NMR spectra were recorded on a JEOL JNM-GSX270 spectrometer (270 MHz for 1 H and 68 MHz for (2a) (1.90 g, 15.7 mmol) in N,N-dimethylformamide (DMF) (50.0 ml) was added 60% NaH (2.51 g, 62.7 mmol) at Ϫ60°C, and the mixture was stirred at 10-15°C for 1 h. 5-Chloromethyl-1-azabicyclo[3.3.0]octane hydrochloride (3a) (3.38 g, 17.2 mmol) was added to the mixture at Ϫ60°C. After stirring at 15°C for 3 h, the reaction mixture was poured into 200 ml of ice-water and extracted with AcOEt (600 ml). The extract was washed with brine (50 ml), dried and evaporated in vacuo. The residue was chromatographed on silica gel and eluted with AcOEt-triethylamine (70/1) to give 3.65 g (95.1%) of 4a as a pale yellow oil. IR (neat) In a similar manner to that described in procedure A, a reaction of Nformyl-2-phenylaniline (2c) (286 mg, 1.45 mmol) with 60% NaH (260 mg, 6.50 mmol) and 3a (300 mg, 1.53 mmol), as for 4a, gave 452 mg (97.3%) of N-(1-azabicyclo[3.3.0]octan-5-yl)methyl-N-methyl-2-fluoroaniline (5f) In a similar manner to that described in procedure A, a reaction of 2-fluoro-Nformylaniline (2e) (3.00 g, 21.6 mmol) with 60% NaH (3. In a similar manner to that described in procedure C, a reaction of 2-chloroaniline (1i) (1.46 g, 11.4 mmol), 3a (4.50 g, 22.9 mmol) and K 2 CO 3 (4.74 g, 34.3 mmol) in nitrobenzene (80.0 ml) gave 1.27 g (44.1%) of 5i as a brown oil and 870 mg (30.4%) of 10a as a white powder. N-[2-(1-Azabicyclo[3.3 .0]octan-5-yl)ethyl]-2-chloroaniline (5j) In a similar manner to that described in procedure C, a reaction of 1i (600 mg, 4.60 mmol), 3b (1.98 g, 9.42 mmol) and K 2 N-(1-Azabicyclo[3. 
3.1]nonan-5-yl)methyl-2-(trifluoromethyl)
aniline (10c) In a similar manner to that described in procedure C, a reaction of 2-(trifluoromethyl)aniline (1l) (150 mg, 0.931 mmol), 3a (365 mg, 1.86 mmol) and K 2 CO 3 (900 mg, 5.59 mmol) in nitrobenzene (5.00 ml) gave 99.8 mg (37.7%) of 5l as a brown oil and 87. N-(1-Azabicyclo[3.3 .0]octan-5-yl)methyl-4-(trifluoromethyl)aniline (9a) A suspension of 4-fluorobenzotrifluoride (7a) (1.50 g, 9.14 mmol), 5-aminomethyl-1-azabicyclo[3.3.0]octane (8a) (3.20 g, 22.9 mmol), and sodium acetate (500 mg) in pyridine (8.0 ml) was stirred at 170°C for 20 h in a sealed tube and then concentrated in vacuo. To the residue was added 1 N NaOH (30 ml), and the mixture was extracted with AcOEt (80 mlϫ3). The extract was washed with brine (200 ml), dried, and concentrated in vacuo. The residue was chromatographed on silica gel eluting with AcOEt-triethylamine (20/1) to give 708 mg (27.2%) of 9a as a yellow powder, mp 35 1.00 g, 6 .28 mmol) and 8c (2.42 g, 15.7 mmol) in pyridine (15.0 ml) at 45°C for 1 h gave 2.00 g (99.8%) of 9j as a yellow oil. IR (neat) cm 125 g) was stirred at 60°C for 3 h. After being cooled at Ϫ78°C, the resulting mixture was alkalized with 25% ammonia-water (500 ml), and extracted with AcOEt (750 ml). The solution was washed with brine (500 ml), dried, and concentrated in vacuo. Preparation of Rat Brain Homogenate Sprague-Dawley male rats were sacrificed by decapitation, and their brains were excised. The cerebral cortex and the cerebellum were homogenized, respectively, in 10 volumes of ice-cold buffer (0.32 M sucrose) in a Potter-Elvehjem glass homogenizer. The resulting homogenate was centrifuged at 1000ϫg for 10 min at 4°C, the precipitate was removed, and the supernatant was recentrifuged at 40000ϫg for 15 min at 4°C. The pellets thus obtained were washed with each assay buffer by resuspension and recentrifugation. The membrane preparation was stored at Ϫ70°C until required.
[ 3 H]Pirenzepine Binding Inhibition An assay for M 1 receptors was performed according to the method of Flynn and Mash. 10) Frozen rat cerebral cortex membrane was resuspended in an assay buffer (50 mM phosphate buffer, pH 7.4). The membrane suspension, corresponding to 0.6 mg of protein determined by the method of Lowry with bovine serum albumin as the standard, was incubated with approximately 1.0 nM [ 3 H]pirenzepine at 25°C for 60 min. Test compounds were added in a volume of 1ml to give a final assay volume of 2.0 ml. Nonspecific binding was determined using 1 mM atropine. Assays were terminated by the addition of 3 ml of the chilled assay buffer and by rapid filtration under vacuo through Whatman GF/B filter paper which had been previously impregnated with a 0.1% polyethyleneimine solution for 60 min. The filters were washed immediately two times with 3 ml each of the assay buffers. The filter was placed in a scintillation vial, to which 4 ml of ACSII cocktail was added. Radioactivity retained on the filter paper was determined by liquid scintillation counter. All assays were performed in duplicate or triplicate. Competition binding data were analyzed by logic-log analysis to provide the inhibitory concentration (IC 50 ) value of the test compound on 3 H-pirenzepine binding to M 1 receptor.
[ 3 H]Quinuclidinyl benzilate (QNB) Binding Inhibition
The assay for M 2 receptors was performed according to the method of Yamamura and Snyder.
11) A frozen rat cerebellum membrane was resuspended in the assay buffer (50 mM phosphate buffer, pH 7.4). The membrane preparation, corresponding to 0.6 mg of protein determined by the method of Lowry et al., 12) was incubated with approximately 1.0 nM [ 3 H]QNB at 25°C for 60 min. Test compounds were added in a volume of 1 ml to give a final assay volume of 2.0 ml. Non-specific binding was determined using 1 mM QNB. The estimation of filter-bound radioactivity and the data analysis to obtain the IC 50 Passive Avoidance Performance in Scopolamine-Treated Mice A passive avoidance learning test using mice was conducted to examine whether a scopolamine-induced passive avoidance deficit can be improved by the compounds of the present invention.
A training box composed of a light room and a dark room, which both had the same structure, was used. The dark room was designed so that a foot shock is given to a test animal via grids of the floor. An opening is provided on the partitioning wall of the two rooms to let animals in and out freely.
The animal was put in the light room. Immediately after the animal moved into the dark room, a foot shock was given until the animal returned to the light room (acquisition trial). After 24 h from the training, the animal was again put in the light room, and the time required for the animal's moving to the dark room was measured up to 300 s (retention test).
Scopolamine hydrobromide dissolved in physiological saline was administered i.p. to a mouse at a dose of 0.25 mg/kg 15 min before the acquisition trial. Five minutes after the scopolamine administration, a test compound was administered p.o. to the mouse.
The data from the retention test were analyzed to obtain a percent prolongation of the avoidance of the test group based on that of the saline-treated control group.
Biochemical Assays Using Rat Primary Cultured Cells Hippocampal neurons were isolated from rat embryos of day 18 gestation by a trypsin treatment following the protocol of Banker and Cowan, 13) and were maintained for 5-7 d in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. To suppress any growth of the glial cells, the culture was treated with 10 mM cytosine arabinofuranoside for 24 h on the 5th day.
The rate of hydrolysis of inositol phospholipids (PI break down) was assayed in hippocampal neuronal cells, as described previously. 14 
